-
New Clinical Trial Explores Intranasal Insulin as a Potential Support for Spinal Cord Injury Recovery
A new study is investigating whether a nasal spray form of insulin, already used safely in other patient groups, could be a safe and feasible option for people living with spinal cord injury.
-
New Clinical Trial Explores Combination Therapy for Advanced Colorectal Cancer
A new clinical trial is investigating whether combining liposomal irinotecan with TAS102 and bevacizumab can help patients with treatment-resistant metastatic colorectal cancer. The study offers a potential new option for patients who have exhausted standard therapies.
-
New Clinical Trial Explores Combination Therapy for Virus-Related Cancers
A new NIH-sponsored trial is testing whether pairing pomalidomide with the immunotherapy nivolumab can safely and effectively treat a range of cancers caused by viruses, including in patients with HIV.
-
New Clinical Trial Explores Peptide-Based Therapy for Metastatic Colorectal Cancer
A new global trial is investigating whether adding the investigational antibody-drug conjugate telisotuzumab adizutecan to standard chemotherapy regimens can improve outcomes for patients with metastatic colorectal cancer.
-
New Research Explores How Peptides Could Help Ease Chronic Pain in People Living with HIV
A new clinical trial is investigating whether changes in the body’s natural opioid peptides contribute to chronic pain in people with HIV, opening the door to potential new peptide-based therapies.
-
New Clinical Trial Brings Promising Lymphoma Therapy Epcoritamab to Patients in China
A new study is evaluating subcutaneous epcoritamab—alone and combined with standard chemotherapy regimens—for adults with B-cell Non-Hodgkin Lymphoma across 21 sites in China, expanding access to this investigational immunotherapy.
-
New Phase 3 Trial Launches to Study Growth Hormone Therapy for Children with Idiopathic Short Stature
A multicenter Phase III trial is now evaluating Sinotropin AQ, a human growth hormone injection, as a potential treatment to improve height velocity in children with idiopathic short stature.
-
FDA Advisory Panel Recommends Expanded Compounding Access for Six Peptides
An FDA advisory panel has voiced support for allowing continued compounding access to six peptide compounds, a step that could preserve patient and practitioner access while formal approval decisions proceed.
-
FDA Advisory Panel Backs Easing Restrictions on Six Peptides
An FDA advisory panel has voted in favor of loosening restrictions on six peptide compounds, a step that could expand access for researchers and compounding use. The panel’s discussion also touched on continued monitoring to ensure safety as access broadens.
-
Phase II Trial Begins Dosing Patients with LSALT Peptide, a Potential Organ-Protection Therapy
A Phase II clinical trial evaluating LSALT peptide has begun dosing patients, marking a key step forward for a therapy being studied to help protect organ function during high-risk medical procedures.